Nathan (Nate) Cooperman
Emergency physician and researcher (founder/leader in PCARN) who led development of the original PECARN febrile infant rule and other pediatric emergency prediction tools, contributing expertise on prediction-rule methodology.
Best podcasts with Nathan (Nate) Cooperman
Ranked by the Snipd community
Jan 27, 2026 • 48min
Ep 212 PECARN Febrile Young Infant Prediction Tool: When To Safely Forgo LP and Empiric Antibiotics
Dr. Nathan Cooperman, emergency physician and prediction-rule pioneer, and Dr. Bret Burstein, pediatric emergency researcher and lead author of the 2025 JAMA study, discuss modern risk stratification for febrile young infants. They cover biomarker-driven rules (procalcitonin, ANC, UA), which infants were included or excluded, HSV considerations, urine collection nuances, and how to use shared decision-making to safely reduce LPs and antibiotics.
